Research study for women w/ BRCA1 or 2 gene and metastatic bc

Options

Abbott Laboratories is now starting recruitment in several U.S. states for the following study: The Study Evaluating Efficacy and Tolerability of Veliparib in Combination With Temozolomide or in Combination With Carboplatin and Paclitaxel Versus Placebo in Subjects With BRCA1 and BRCA2 Mutation and Metastatic Breast Cancer

For more information, visit the ClinicalTrials.gov page for this study.

Comments

Categories